Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in India-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in India

Published:2023-11-07 Issue:1 Volume:28 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Seth Tulika¹,Garg Kapil²,Mandal Prakas Kumar³,Datta Anupam⁴,Verma Shailendra⁵,Hanagavadi Suresh⁶,Thota Usha Rani⁷

Affiliation:

1. Department of Hematology, AIIMS, New Delhi, India

2. Department of Pediatric Medicine, SMS Medical College, Jaipur, India

3. Department of Hematology, NRS Medical College, Kolkata, India

4. Department of Medicine, Assam Medical College and Hospital, Dibrugarh, India

5. Department of Clinical Hematology, King George’s Medical University, Lucknow, India

6. Department of Pathology, JJM Medical College, Davangere, India

7. Department of Pediatrics, Osmania Medical College, Hyderabad, India

Funder

Takeda Biopharmaceuticals India Private Limited

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2023.2277497

Reference44 articles.

1. Effect of tertiary prophylaxis with low-dose factor VIII in quality of life in adult patients with severe hemophilia A

2. Epidemiology & social costs of haemophilia in India;Kar A;Indian J Med Res,2014

3. Report on the Annual Global Survey 2020 is published by the World Federation of Hemophilia. (2020). https://www1.wfh.org/publications/files/pdf-2045.pdf.

4. Consensus Statement of the Indian Academy of Pediatrics in Diagnosis and Management of Hemophilia

5. Safety and efficacy of secondary prophylactic in patients with severe hemophilia type A and B: a systematic review and meta-analysis study;Goudarzi R;Health Technol Assess Action,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Joint health and pain in the changing hemophilia treatment landscape;Expert Review of Hematology;2024-07-15

2. Kinetic Modeling for BT200 to Predict the Level of Plasma-Derived Coagulation Factor VIII in Humans;The AAPS Journal;2024-07-12

3. Improving Hemophilia Care in Low- and Middle-Income Countries: Addressing Challenges and Enhancing Quality of Life;Cureus;2024-06-21

4. The Last 50 years of Hemophilia Care: A Golden Era;Indian Pediatrics;2024-05

5. Expert Opinions on the Management of Hemophilia A in India: The Role of Emicizumab;Cureus;2024-04-24